Logo image of BGS

B&G FOODS INC (BGS) Stock Fundamental Analysis

USA - NYSE:BGS - US05508R1068 - Common Stock

4.52 USD
-0.02 (-0.44%)
Last: 9/18/2025, 9:40:52 AM
Fundamental Rating

3

Taking everything into account, BGS scores 3 out of 10 in our fundamental rating. BGS was compared to 89 industry peers in the Food Products industry. BGS may be in some trouble as it scores bad on both profitability and health. BGS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BGS was profitable.
In the past year BGS had a positive cash flow from operations.
In multiple years BGS reported negative net income over the last 5 years.
BGS had a positive operating cash flow in each of the past 5 years.
BGS Yearly Net Income VS EBIT VS OCF VS FCFBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.62%, BGS is doing worse than 73.03% of the companies in the same industry.
BGS's Return On Equity of -44.65% is on the low side compared to the rest of the industry. BGS is outperformed by 73.03% of its industry peers.
BGS's Return On Invested Capital of 5.46% is in line compared to the rest of the industry. BGS outperforms 59.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BGS is significantly below the industry average of 28.32%.
Industry RankSector Rank
ROA -7.62%
ROE -44.65%
ROIC 5.46%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
BGS Yearly ROA, ROE, ROICBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

BGS has a better Operating Margin (9.93%) than 73.03% of its industry peers.
In the last couple of years the Operating Margin of BGS has declined.
With a Gross Margin value of 21.37%, BGS perfoms like the industry average, outperforming 50.56% of the companies in the same industry.
In the last couple of years the Gross Margin of BGS has remained more or less at the same level.
Industry RankSector Rank
OM 9.93%
PM (TTM) N/A
GM 21.37%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
BGS Yearly Profit, Operating, Gross MarginsBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

BGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BGS has more shares outstanding than it did 1 year ago.
BGS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BGS is higher compared to a year ago.
BGS Yearly Shares OutstandingBGS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BGS Yearly Total Debt VS Total AssetsBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BGS has an Altman-Z score of 1.37. This is a bad value and indicates that BGS is not financially healthy and even has some risk of bankruptcy.
BGS's Altman-Z score of 1.37 is on the low side compared to the rest of the industry. BGS is outperformed by 62.92% of its industry peers.
The Debt to FCF ratio of BGS is 15.92, which is on the high side as it means it would take BGS, 15.92 years of fcf income to pay off all of its debts.
BGS has a Debt to FCF ratio (15.92) which is in line with its industry peers.
A Debt/Equity ratio of 3.96 is on the high side and indicates that BGS has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 3.96, BGS is doing worse than 89.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF 15.92
Altman-Z 1.37
ROIC/WACC0.77
WACC7.06%
BGS Yearly LT Debt VS Equity VS FCFBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

BGS has a Current Ratio of 2.93. This indicates that BGS is financially healthy and has no problem in meeting its short term obligations.
BGS has a Current ratio of 2.93. This is amongst the best in the industry. BGS outperforms 80.90% of its industry peers.
A Quick Ratio of 0.89 indicates that BGS may have some problems paying its short term obligations.
BGS has a Quick ratio (0.89) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 0.89
BGS Yearly Current Assets VS Current LiabilitesBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for BGS have decreased strongly by -37.35% in the last year.
The earnings per share for BGS have been decreasing by -15.66% on average. This is quite bad
Looking at the last year, BGS shows a decrease in Revenue. The Revenue has decreased by -6.91% in the last year.
Measured over the past years, BGS shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)-37.35%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%-50%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.54%

3.2 Future

Based on estimates for the next years, BGS will show a small growth in Earnings Per Share. The EPS will grow by 1.86% on average per year.
The Revenue is expected to decrease by -1.92% on average over the next years.
EPS Next Y-27.28%
EPS Next 2Y-12.75%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue Next Year-5.14%
Revenue Next 2Y-3.16%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BGS Yearly Revenue VS EstimatesBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
BGS Yearly EPS VS EstimatesBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.69, which indicates a very decent valuation of BGS.
Compared to the rest of the industry, the Price/Earnings ratio of BGS indicates a rather cheap valuation: BGS is cheaper than 88.76% of the companies listed in the same industry.
BGS is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.48, the valuation of BGS can be described as reasonable.
BGS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BGS is cheaper than 95.51% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.70. BGS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.69
Fwd PE 8.48
BGS Price Earnings VS Forward Price EarningsBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.54% of the companies in the same industry are more expensive than BGS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BGS is valued cheaply inside the industry as 95.51% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.89
EV/EBITDA 8.44
BGS Per share dataBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.75%
EPS Next 3Y1.86%

5

5. Dividend

5.1 Amount

BGS has a Yearly Dividend Yield of 16.49%, which is a nice return.
Compared to an average industry Dividend Yield of 5.03, BGS pays a better dividend. On top of this BGS pays more dividend than 97.75% of the companies listed in the same industry.
BGS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 16.49%

5.2 History

The dividend of BGS decreases each year by -16.37%.
BGS has paid a dividend for at least 10 years, which is a reliable track record.
BGS has decreased its dividend recently.
Dividend Growth(5Y)-16.37%
Div Incr Years0
Div Non Decr Years1
BGS Yearly Dividends per shareBGS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of BGS are negative and hence is the payout ratio. BGS will probably not be able to sustain this dividend level.
DP-26.91%
EPS Next 2Y-12.75%
EPS Next 3Y1.86%
BGS Yearly Income VS Free CF VS DividendBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

B&G FOODS INC

NYSE:BGS (9/18/2025, 9:40:52 AM)

4.52

-0.02 (-0.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners76.94%
Inst Owner Change5%
Ins Owners3.76%
Ins Owner Change17.47%
Market Cap361.60M
Analysts47.69
Price Target4.59 (1.55%)
Short Float %19.49%
Short Ratio5.92
Dividend
Industry RankSector Rank
Dividend Yield 16.49%
Yearly Dividend0.76
Dividend Growth(5Y)-16.37%
DP-26.91%
Div Incr Years0
Div Non Decr Years1
Ex-Date09-30 2025-09-30 (0.19)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-53.51%
Min EPS beat(2)-74.14%
Max EPS beat(2)-32.87%
EPS beat(4)1
Avg EPS beat(4)-35.28%
Min EPS beat(4)-74.14%
Max EPS beat(4)0.96%
EPS beat(8)3
Avg EPS beat(8)-19.64%
EPS beat(12)6
Avg EPS beat(12)-1.04%
EPS beat(16)6
Avg EPS beat(16)-6.9%
Revenue beat(2)0
Avg Revenue beat(2)-5.11%
Min Revenue beat(2)-8.34%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-3.51%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)-0.33%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)3
Avg Revenue beat(12)-1.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.99%
PT rev (1m)-14.29%
PT rev (3m)-18.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.28%
EPS NY rev (1m)-11.24%
EPS NY rev (3m)-9.97%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)-3.81%
Revenue NY rev (1m)-1.81%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE 8.69
Fwd PE 8.48
P/S 0.19
P/FCF 2.89
P/OCF 2.33
P/B 0.72
P/tB N/A
EV/EBITDA 8.44
EPS(TTM)0.52
EY11.5%
EPS(NY)0.53
Fwd EY11.79%
FCF(TTM)1.56
FCFY34.58%
OCF(TTM)1.94
OCFY43%
SpS23.28
BVpS6.27
TBVpS-16.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.62%
ROE -44.65%
ROCE 6.91%
ROIC 5.46%
ROICexc 5.57%
ROICexgc 18.19%
OM 9.93%
PM (TTM) N/A
GM 21.37%
FCFM 6.71%
ROA(3y)-3.53%
ROA(5y)-1.07%
ROE(3y)-19.04%
ROE(5y)-6.78%
ROIC(3y)5.46%
ROIC(5y)5.48%
ROICexc(3y)5.54%
ROICexc(5y)5.56%
ROICexgc(3y)18%
ROICexgc(5y)19.45%
ROCE(3y)6.91%
ROCE(5y)6.94%
ROICexcg growth 3Y2.98%
ROICexcg growth 5Y-1.12%
ROICexc growth 3Y8.5%
ROICexc growth 5Y3.01%
OM growth 3Y1.19%
OM growth 5Y-2.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y-1.1%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF 15.92
Debt/EBITDA 7.28
Cap/Depr 34.79%
Cap/Sales 1.63%
Interest Coverage 1.28
Cash Conversion 57.06%
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 0.89
Altman-Z 1.37
F-Score4
WACC7.06%
ROIC/WACC0.77
Cap/Depr(3y)29.41%
Cap/Depr(5y)36.55%
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.35%
EPS 3Y-27.93%
EPS 5Y-15.66%
EPS Q2Q%-50%
EPS Next Y-27.28%
EPS Next 2Y-12.75%
EPS Next 3Y1.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-2.05%
Revenue growth 5Y3.08%
Sales Q2Q%-4.54%
Revenue Next Year-5.14%
Revenue Next 2Y-3.16%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A
EBIT growth 1Y-45.37%
EBIT growth 3Y-0.88%
EBIT growth 5Y0.92%
EBIT Next Year23.68%
EBIT Next 3Y9.52%
EBIT Next 5YN/A
FCF growth 1Y28.12%
FCF growth 3Y27.08%
FCF growth 5Y90.64%
OCF growth 1Y32.55%
OCF growth 3Y11.71%
OCF growth 5Y23%